Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | APEX1 | P27695 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | HTR7 | P34969 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.54 |
| ▸ | FBP1 | P09467 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3022330 | 1.00 | CYP1A2 (0.63) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| SCHEMBL3026942 | 1.00 | CYP1A2 (0.63) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| Hydrochloric Acid SCHEMBL9097221 | 0.98 | CYP1A2 (0.61) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| Hydrochloric Acid SCHEMBL9097230 | 0.98 | CYP1A2 (0.61) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| Hydrochloric Acid SCHEMBL9097519 | 0.98 | CYP1A2 (0.61) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| SCHEMBL10989220 | 0.87 | CYP1A2 (0.67) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| Hydrochloric Acid SCHEMBL9098773 | 0.87 | CYP1A2 (0.58) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| SCHEMBL10037466 | 0.84 | APEX1 (0.64) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| SCHEMBL3026939 | 0.84 | CYP1A2 (0.63) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 | |
| SCHEMBL3911169 | 0.84 | APEX1 (0.68) | CYP1A2CYP2D6CYP3A4CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197914-A1 | Purine Derivatives as Adenosine Al Receptor Ligands | NOVARTIS AG (CH) | 2010-08-05 | — | — | US | disclosed |
| EP-2205601-A1 | PURINE DERIVATIVES AS ADENOSINE AL RECEPTOR LIGANDS | Novartis Ag (CH) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009050199-A1 | PURINE DERIVATIVES AS ADENOSINE AL RECEPTOR LIGANDS | NOVARTIS AG (CH) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197914-A1 | Purine Derivatives as Adenosine Al Receptor Ligands | ADORA2A, ADORA1, ADORA3 | CYP1A2 343/4885CYP2D6 337/4885CYP3A4 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.